68Ga
Total Payments
$156,573
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $156,573 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $156,573 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| FAP Imaging: Imaging of Solid Tumors Using 68Ga-FAP-2286 | Clovis Oncology, Inc. | $156,573 | 0 |
Top Doctors Receiving Payments for 68Ga
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Francisco, CA | $156,573 | 2 |
Ad
Manufacturing Companies
- Clovis Oncology, Inc. $156,573
Product Information
- Type Drug
- Total Payments $156,573
- Total Doctors 0
- Transactions 2
About 68Ga
68Ga is a drug associated with $156,573 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Clovis Oncology, Inc..
Payment data is available from 2020 to 2020. In 2020, $156,573 was paid across 2 transactions to 0 doctors.
The most common payment nature for 68Ga is "Unspecified" ($156,573, 100.0% of total).
68Ga is associated with 1 research study, including "FAP Imaging: Imaging of Solid Tumors Using 68Ga-FAP-2286" ($156,573).